BiochemistrybioRxiv
A Highly Potent SARS-CoV-2 Blocking Lectin Protein
R. E. Ahan, A. Hanifehnezhad, E. Sahin Kehribar…·U. Seker
This paper demonstrates that griffithsin (GRFT) blocks SARS-CoV-2 entry into cell lines and mouse models by binding to the spike protein, suggesting its potential as a prophylactic drug against SARS-CoV-2 variants.